Evidence / Sources / E22
Goller SS et al. MOCART 2.0 for retropatellar autologous chondrocyte transplantation. Knee 2022
What it can tell you
The one imaging finding in this literature aimed at the compartment this site's owner has: in retropatellar transplantation, subchondral changes visible at three months were the best early predictor (accuracy 0.76) of a meaningful IKDC improvement at twelve. An early MRI is otherwise mostly reassurance; this is a reason to read one.
What it cannot
What to do about it. Nothing here tests an intervention — a worrying three-month subchondral appearance has no studied response, and the finding is prognostic rather than actionable. Nor does it extend past twelve months.
Everything on this site that leans on E22 — 0 claims
Nothing cites this source yet — it is part of the vetted evidence base for content still being written.
Read it like a sceptic
n=38, single centre, and 0.76 accuracy means roughly one patient in four is called wrong.
Reading it the other way round is the temptation to resist: this does not license treating a clean three-month MRI as permission to progress faster.
Population
Retropatellar MACT
Selection policy
Sources enter the registry through docs/research — the evidence table records design, population, and size for every entry, and pages cannot cite anything outside it.